1. Home
  2. ZYXI vs BAFN Comparison

ZYXI vs BAFN Comparison

Compare ZYXI & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • BAFN
  • Stock Information
  • Founded
  • ZYXI 1996
  • BAFN 1999
  • Country
  • ZYXI United States
  • BAFN United States
  • Employees
  • ZYXI N/A
  • BAFN N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BAFN Savings Institutions
  • Sector
  • ZYXI Health Care
  • BAFN Finance
  • Exchange
  • ZYXI Nasdaq
  • BAFN Nasdaq
  • Market Cap
  • ZYXI 72.3M
  • BAFN 63.2M
  • IPO Year
  • ZYXI N/A
  • BAFN N/A
  • Fundamental
  • Price
  • ZYXI $2.41
  • BAFN $13.09
  • Analyst Decision
  • ZYXI Buy
  • BAFN
  • Analyst Count
  • ZYXI 3
  • BAFN 0
  • Target Price
  • ZYXI $5.50
  • BAFN N/A
  • AVG Volume (30 Days)
  • ZYXI 132.8K
  • BAFN 17.2K
  • Earning Date
  • ZYXI 07-31-2025
  • BAFN 07-29-2025
  • Dividend Yield
  • ZYXI N/A
  • BAFN 2.24%
  • EPS Growth
  • ZYXI N/A
  • BAFN 102.38
  • EPS
  • ZYXI N/A
  • BAFN 1.90
  • Revenue
  • ZYXI $172,401,000.00
  • BAFN $78,211,000.00
  • Revenue This Year
  • ZYXI N/A
  • BAFN N/A
  • Revenue Next Year
  • ZYXI $19.55
  • BAFN N/A
  • P/E Ratio
  • ZYXI N/A
  • BAFN $7.96
  • Revenue Growth
  • ZYXI N/A
  • BAFN 0.67
  • 52 Week Low
  • ZYXI $1.66
  • BAFN $11.98
  • 52 Week High
  • ZYXI $9.42
  • BAFN $19.75
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 49.49
  • BAFN 40.24
  • Support Level
  • ZYXI $2.46
  • BAFN $14.50
  • Resistance Level
  • ZYXI $2.60
  • BAFN $15.28
  • Average True Range (ATR)
  • ZYXI 0.15
  • BAFN 0.34
  • MACD
  • ZYXI 0.01
  • BAFN -0.01
  • Stochastic Oscillator
  • ZYXI 46.75
  • BAFN 0.00

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

Share on Social Networks: